Gain Therapeutics, Inc. (GANX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 18.22M | 22.24M | 10.52M | 9.31M | 11.15M | 11.6M | 13.74M | 18.54M | 13.86M | 17.78M | 13.24M | 17.31M |
| Cash & Short-Term Investments | 16.54M | 20.84M | 8.81M | 6.69M | 9.07M | 10.39M | 12.05M | 16.94M | 12.66M | 16.79M | 12.23M | 16.19M |
| Cash Only | 16.54M | 20.84M | 8.81M | 6.69M | 9.07M | 10.39M | 12.05M | 16.94M | 10.64M | 11.79M | 4.27M | 6.32M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.02M | 5M | 7.96M | 9.87M |
| Accounts Receivable | 0 | 802.69K | 788.61K | 0 | 0 | 765.76K | 373.73K | 313.25K | 249.13K | 242.58K | 101.91K | 160.73K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.68M | 596.82K | 0 | 1.41M | 886.62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 516.7K | 581.84K | 454.41K | 527.28K | 472.65K | 521.41K | 624.32K | 657.31K | 714.66K | 830.46K | 855.89K | 952.43K |
| Property, Plant & Equipment | 355.01K | 409.01K | 269.99K | 329.39K | 281.17K | 323.33K | 401.19K | 449.81K | 496.06K | 585.18K | 618.15K | 698.33K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 102.84K | 114.61K | 127.86K | 126.29K | 134.27K | 156.26K | 158.15K | 169.25K | 193.38K | 189.24K | 204.55K |
| Long-Term Investments | 0 | 36.3K | 36.12K | 0 | 0 | 31.7K | 0 | 31.8K | 0 | 34.02K | 31.14K | 31.82K |
| Other Non-Current Assets | 161.69K | 33.7K | 33.69K | 70.03K | 65.18K | 32.11K | 66.88K | 17.55K | 49.36K | 17.89K | 48.5K | 49.55K |
| Total Assets | 18.74M | 22.82M | 10.97M | 9.83M | 11.62M | 12.12M | 14.37M | 19.2M | 14.58M | 18.61M | 14.1M | 18.26M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 61.2% | 88.22% | -23.63% | -48.77% | -20.26% | -34.85% | 1.9% | 5.12% | -31.64% | -22.78% | -50.23% | -42.74% |
| Total Current Liabilities | 3.89M | 3.35M | 4.17M | 5.2M | 5.03M | 3.91M | 4.59M | 6.52M | 5M | 4.95M | 5.76M | 5.59M |
| Accounts Payable | 1.52M | 825.03K | 1.58M | 2.71M | 2.15M | 946.26K | 1.1M | 2.05M | 1.41M | 1.32M | 1.38M | 924.39K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 116.63K | 220.75K | 125.55K | 126.11K | 113.12K | 110.18K | 118.28K | 111.05K | 110.85K | 118.8K | 109.28K | 111.64K |
| Deferred Revenue (Current) | 0 | 0 | 11.29K | 0 | 0 | 252.21K | 708.03K | 710K | 914.76K | 1.12M | 1.35M | 1.07M |
| Other Current Liabilities | 2.25M | 2.26M | 2.34M | 47.85K | 235.81K | 18.49K | 21K | 2.06M | 74.68K | 1.38M | 1.68M | 2.35M |
| Current Ratio | 4.69x | 6.63x | 2.52x | 1.79x | 2.22x | 2.97x | 2.99x | 2.84x | 2.77x | 3.59x | 2.30x | 3.10x |
| Quick Ratio | 4.69x | 6.63x | 2.52x | 1.79x | 2.22x | 2.97x | 2.99x | 2.84x | 2.77x | 3.59x | 2.30x | 3.10x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 844.91K | 901.83K | 891.65K | 940.89K | 815.92K | 872.99K | 861.49K | 888.47K | 930.99K | 1.08M | 1M | 1.58M |
| Long-Term Debt | 182.13K | 300.08K | 298.8K | 325.36K | 314.48K | 328.33K | 376.13K | 375.35K | 396.84K | 449.05K | 434.94K | 466.64K |
| Capital Lease Obligations | 0 | 211.24K | 65.03K | 92.85K | 30.59K | 53.6K | 96.22K | 134.32K | 177.37K | 229.85K | 263.46K | 330.07K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 662.78K | 390.51K | 527.83K | 522.68K | 470.86K | 443.62K | 323.27K | 298.43K | 292.49K | 307.45K | 160.51K | 174.19K |
| Total Liabilities | 4.73M | 4.25M | 5.06M | 6.14M | 5.84M | 4.78M | 5.46M | 7.41M | 5.94M | 6.03M | 6.77M | 7.17M |
| Total Debt | 298.76K | 732.07K | 605.28K | 680.64K | 606.86K | 653.01K | 769.41K | 807.57K | 889.62K | 1.03M | 1.04M | 1.14M |
| Net Debt | -16.24M | -20.11M | -8.2M | -6.01M | -8.46M | -9.73M | -11.28M | -16.13M | -9.75M | -10.77M | -3.23M | -5.18M |
| Debt / Equity | 0.02x | 0.04x | 0.10x | 0.18x | 0.10x | 0.09x | 0.09x | 0.07x | 0.10x | 0.08x | 0.14x | 0.10x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 14.01M | 18.56M | 5.91M | 3.7M | 5.78M | 7.34M | 8.91M | 11.78M | 8.64M | 12.58M | 7.33M | 11.09M |
| Equity Growth % | 142.35% | 152.94% | -33.67% | -68.64% | -33.12% | -41.65% | 21.53% | 6.24% | -42.91% | -33.38% | -67.65% | -58.94% |
| Book Value per Share | 0.33 | 0.56 | 0.17 | 0.12 | 0.20 | 0.27 | 0.34 | 0.61 | 0.48 | 0.78 | 0.58 | 0.90 |
| Total Shareholders' Equity | 14.01M | 18.56M | 5.91M | 3.7M | 5.78M | 7.34M | 8.91M | 11.78M | 8.64M | 12.58M | 7.33M | 11.09M |
| Common Stock | 4.25K | 4.21K | 3.6K | 3.08K | 2.88K | 2.71K | 2.6K | 2.52K | 1.8K | 1.62K | 1.28K | 1.26K |
| Retained Earnings | -101.36M | -101.36M | -96.82M | -91.53M | -85.72M | -81.19M | -77.43M | -72.94M | -64.8M | -60.78M | -56.06M | -51.34M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 996.95K | 776.87K | 563.22K | 584.08K | -119.86K | -247.55K | 242.81K | 12.46K | 21.86K | 247.24K | 90.66K | 134.32K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |